Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +0.84% | -3.23% | +14.29% |
Mar. 19 | Aclaris Therapeutics, Inc. Announces Board Resignations | CI |
Feb. 27 | Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 7.76M | Sales 2025 * | 8.69M | Capitalization | 85.52M |
---|---|---|---|---|---|
Net income 2024 * | -73M | Net income 2025 * | -70M | EV / Sales 2024 * | 1.84 x |
Net cash position 2024 * | 71.24M | Net cash position 2025 * | 157M | EV / Sales 2025 * | -8.28 x |
P/E ratio 2024 * |
-1.23
x | P/E ratio 2025 * |
-1.32
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.23% |
Latest transcript on Aclaris Therapeutics, Inc.
1 day | +0.84% | ||
1 week | -3.23% | ||
Current month | -3.23% | ||
1 month | +1.69% | ||
3 months | -2.44% | ||
6 months | -73.80% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 12-06-30 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 16-12-31 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 17-08-08 |
Maxine Gowen
BRD | Director/Board Member | 66 | 19-07-01 |
Andrew Powell
BRD | Director/Board Member | 66 | 17-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.2 | +0.84% | 445,216 |
24-04-25 | 1.19 | +1.71% | 1,626,758 |
24-04-24 | 1.17 | -4.10% | 1,439,407 |
24-04-23 | 1.22 | 0.00% | 637,744 |
24-04-22 | 1.22 | -1.61% | 663,173 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 85.52M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ACRS Stock